Article
A novel defined cuproptosis-related gene signature for predicting the prognosis of lung adenocarcinoma
15 Aug 2022
Abstract excerpt
Lung adenocarcinoma (LUAD) has become the most prevalent histologic subset of primary lung cancer, and effective innovative prognostic models are needed to enhance the feasibility of targeted therapies for the disease. Programmed cell death (PCD) performs an integral function in the origin and treatment of cancer. Some PCD-related effective signatures for predicting prognosis in LUAD patients could provide...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
